Revenue (Quarterly)

Revenue: The sum of all revenue fields included for a company's operating activities.

Treace Medical Concepts, Inc. (TMCI) had Revenue of $50.21M for the most recently reported fiscal quarter, ending 2025-09-30.

Quarterly Annual

Figures for fiscal quarter ending 2025-09-30

Income Statement Financials
Revenue	$50.21M
Net Income	$-16.29M
Cost of Goods Sold	$10.51M
Gross Profit	$39.71M
Operating Expenses	$65.89M
Operating Income	$-15.68M
Non-Operating Income/Expense	$-0.61M
Pre-Tax Income	$-16.29M
Normalized Pre-Tax Income	$-16.29M
Income after Taxes	$-16.29M
Income from Continuous Operations	$-16.29M
Consolidated Net Income/Loss	$-16.29M
Normalized Income after Taxes	$-16.29M
EBIT	$-15.68M
EBITDA	$-12.83M
Weighted-Average Shares Outstanding (Basic)	63.52M
Weighted-Average Shares Outstanding (Diluted)	63.52M
Earnings per Share (EPS) (Basic)	$-0.26
Earnings per Share (EPS) (Diluted)	$-0.26
Balance Sheet Financials
Current Assets	$138.00M
Property, Plant, and Equipment	$29.97M
Long-Term Assets	$58.59M
Total Assets	$196.59M
Current Liabilities	$40.91M
Long-Term Debt	$53.53M
Long-Term Liabilities	$66.50M
Total Liabilities	$107.40M
Common Equity	$89.19M
Tangible Shareholders Equity	$69.01M
Shareholders Equity	$89.19M
Common Shares Outstanding	63.70M
Cash Flow Statement Financials
Cash Flow from Operating Activities	$-7.94M
Cash Flow from Investing Activities	$3.58M
Cash Flow from Financial Activities	$0.69M
Beginning Cash	$11.35M
End Cash	$7.69M
Increase/Decrease in Cash	$-3.66M
Stock-Based Compensation	$26.27M
Common Stock Dividends Paid	--
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	3.37
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	0.38
Debt to Equity Ratio	0.60
Gross Margin	79.07%
Operating Margin	-31.22%
EBIT Margin	-31.22%
EBITDA Margin	--
Pre-Tax Profit Margin	-32.44%
Profit Margin	-32.44%
Free Cash Flow	$-19.06M
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	0.26
Inventory Turnover	0.25
Receiveable Turnover	1.52
Days Sales in Receivables	59.07
Return on Equity	-18.26%
Return on Tangible Equity	-23.60%
Return on Assets	-8.29%
Return on Investments	-11.41%
Book Value Per Share	$1.40
Free Cash Flow per Share	$-0.30
Operating Cash Flow per Share	$-0.13

Data from Zacks Investment Research, Inc.